Repros Therapeutics Inc RPRX shares are trading higher by $0.09 at $1.97 in Tuesday's session. The issue has received a slight boost from positive clinical data for Proellex.
Following a higher open, it went a nickel higher to $2.15 before reversing course. That is just shy of a trio of highs from October 6-10 from $2.16-$2.19.
The ensuing decline has taken the issue under $2.00, so far reaching $1.93. That is just ahead of the top of Monday's range ($1.88).
The issue is attempting to close over $2.00 for the first time since October 14, when it ended the session at $2.03.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
